Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas.

International journal of oncology - 1 Feb 2008

Engelsen Ingeborg B, Stefansson Ingunn M, Beroukhim Rameen, Sellers William R, Meyerson Matthew, Akslen Lars A, Salvesen Helga B

Abstract excerpt

Gene alterations and overexpression of various oncogenes and cell-cycle regulators are important in tumor development. In a population based series of 316 endometrial carcinomas with long and complete follow-up we investigated the distribution of HER-2/neu and EGFR expression and copy number alteration in endometrial cancers. HER-2/ neu, EGFR and Ki-67 expression in curettage and hysterectomy specimens were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Monoclonal, Humanized

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antigens, Neoplasm

Share to Endometrial Neoplasms

Share to ErbB Receptors

Share to Oligonucleotide Array Sequence Analysis

Share to Receptor, ErbB-2

Share to Trastuzumab

Source

Identifiers

PMID: 18202752

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas.PMID 18202752Read ↗

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas.Semantic proximity Read ↗

Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas.Semantic proximity Read ↗

ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtype.Semantic proximity Read ↗

Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions.Semantic proximity Read ↗

Detection of ERBB2 amplification in uterine serous carcinoma by next-generation sequencing: an approach highly concordant with standard assaysSemantic proximity Read ↗

ERBB2 amplification is a late event in the pathogenesis of high-grade endometrial carcinomas with heterogeneous HER2 expression.Semantic proximity Read ↗

HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant.Semantic proximity Read ↗

High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.Semantic proximity Read ↗

Amplification of c‐erbB2 oncogeneSemantic proximity Read ↗

Decreased HER2 expression in endometrial cancer following anti‐HER2 therapySemantic proximity Read ↗

Characteristics of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Endometrial Serous Carcinoma: Implications for Clinical HER2 Testing and InterpretationSemantic proximity Read ↗

HER2 Evaluation in Uterine Serous Carcinoma: Diagnostic Agreement Between Biopsy and Resection SamplesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.